Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia
Studying Zika virus disease
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Institut Pasteur
- Principal Investigator
- Arnaud FontanetInstitut Pasteur
- Intervention
- Differential diagnosis for infectious causes of microcephaly(diagnostic_test)
- Enrollment
- 150 target
- Eligibility
- All sexes
- Timeline
- 2019 – 2021
Study locations (8)
- Central Hospital Maternity, Yaoundé, Cameroon
- Essos Hospital Centre Maternity, Yaoundé, Cameroon
- Guangzhou Women's and Children's Hospital, Guangzhou, China
- General Hospital Abobo-Sud, Abidjan, Côte d’Ivoire
- General Hospital of Yopougon-Attie, Abidjan, Côte d’Ivoire
- Castle Street Hospital for Women, Colombo, Sri Lanka
- De Soyza Hospital for Women, Colombo, Sri Lanka
- Tu Du Hospital, Ho Chi Minh City, Vietnam
Collaborators
Centre Pasteur du Cameroun · Guangzhou Women and Children's Medical Center · Institut Pasteur of Cote d'Ivoire · Pasteur Institute, Ho Chi Minh City · Tu Du Hospital · Perinatal Society of Sri Lanka · University of Colombo · University of Lausanne · University of Lausanne Hospitals · The University of Hong Kong · Ministry of Health of Sri Lanka · Central Hospital Maternity · Essos Hospital Center · Guangzhou Baiyun Maternal and Child Health Hospital · General Hospital of Yopougon-Attie · General Hospital Abobo-Sud · Castle Street Hospital for Women · De Soyza Hospital for Women
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03922594 on ClinicalTrials.govOther trials for Zika virus disease
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT04398901Neurodevelopmental Outcomes in ZIKV-Exposed ChildrenChildren's National Research Institute
- ACTIVE NOT RECRUITINGPHASE3NCT03037164INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsCerus Corporation
- RECRUITINGNCT01386424Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsNational Institute of Allergy and Infectious Diseases (NIAID)